This paper is in the following e-collection/theme issue:

Innovations and Technology in Cancer Care (431) Nursing in a Hospital Setting (104) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1428) Wearable Devices and Sensors (903) Mobile Health (mhealth) (2982) Mobile Apps for Cancer Care and Cancer Prevention and Screening (210)

Published on in Vol 8, No 4 (2022): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39271, first published .
Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study

Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study

Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study

Authors of this article:

Meghan B Skiba1, 2 Author Orcid Image ;   Graham Harker3 Author Orcid Image ;   Carolyn Guidarelli4 Author Orcid Image ;   Mahmoud El-Gohary5 Author Orcid Image ;   Fay Horak3, 5 Author Orcid Image ;   Eric J Roeland4, 6 Author Orcid Image ;   Rebecca Silbermann4, 6 Author Orcid Image ;   Brandon Hayes-Lattin4, 6 Author Orcid Image ;   Kerri Winters-Stone4 Author Orcid Image
Article Authors Cited by (4) Tweetations (4) Metrics

Meghan B Skiba   1, 2 , MS, MPH, PhD, RDN ;   Graham Harker   3 , MPH ;   Carolyn Guidarelli   4 , MPH ;   Mahmoud El-Gohary   5 , PhD ;   Fay Horak   3, 5 , PhD, PT ;   Eric J Roeland   4, 6 , MD ;   Rebecca Silbermann   4, 6 , MD, MMS ;   Brandon Hayes-Lattin   4, 6 , MD ;   Kerri Winters-Stone   4 , PhD

1 Biobehavioral Health Science Division, College of Nursing, University of Arizona, Tucson, AZ, United States

2 The University of Arizona Cancer Center, University of Arizona, Tucson, AZ, United States

3 Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR, United States

4 Division of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States

5 APDM, Inc, a division of Clario International, Portland, OR, United States

6 Division of Hematology and Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR, United States

Corresponding Author:

  • Kerri Winters-Stone, PhD
  • Division of Oncological Sciences
  • Knight Cancer Institute
  • Oregon Health & Science University
  • 3181 SW Sam Jackson Park Rd
  • KCRB-CPC
  • Portland, OR, 97239
  • United States
  • Phone: 1 5034940813
  • Fax: 1 5033468296
  • Email: wintersk@ohsu.edu